论文部分内容阅读
1960年5月至1994年4月，我院共收治153例子宫肉瘤。治疗后65例发生局部复发或远处转移，复发转移率42．5％平均复发转移时间12．9个月，中位时间7个月。76．9％的病人在2年内复发，单纯局部复发23例（354％），单纯远处转移28例（43．1％），局部加远处转移14例（21．5％）。本文分析了复发转移特点及复发有关因素。手术是子宫肉瘤主要治疗手段，术后输以放疗可降低盆腔复发率，尤其是内膜间质肉瘤，而术后加化疗未能降低远处转移率。复发转移与病理类型无关，与病变范围有一定关系。复发后积极治疗对延长病人生命有明显意义。
May 1960 to April 1994, our hospital received a total of 153 cases of uterine sarcoma. After treatment, 65 cases had local recurrence or distant metastasis, the recurrence and metastasis rate was 42.5%, the average recurrence and metastasis time was 12.9 months, and the median time was 7 months. 76.9% of the patients relapsed within 2 years. Only local recurrence occurred in 23 cases (354%), distant metastasis in 28 cases (43.1%) and distant metastasis in 14 cases (21.5%). This article analyzes the characteristics of recurrence and metastasis and relapse related factors. Surgery is the main treatment of uterine sarcoma, postoperative radiotherapy can reduce the pelvic recurrence rate, especially in the endometrial stromal sarcoma, and postoperative chemotherapy failed to reduce the distant metastasis rate. Recurrence and metastasis and pathological type has nothing to do with the extent of the lesion has a certain relationship. Active treatment after recurrence has the obvious meaning to prolong the patient’s life.